Neovacs S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was EUR 31,309 compared to EUR 277,678 a year ago. Operating loss was EUR 3.491 million compared to EUR 8.174 million a year ago. Net loss was EUR 6.142 million compared to EUR 7.548 million a year ago.